article thumbnail

New Eli Lilly Eczema Drug Brings Competition and Dosing Edge Versus Sanofi, LEO Pharma Meds

MedCity News

billion acquisition of Dermira in 2020. The post New Eli Lilly Eczema Drug Brings Competition and Dosing Edge Versus Sanofi, LEO Pharma Meds appeared first on MedCity News. Eli Lilly drug Ebglyss is now FDA-approved for atopic dermatitis, an inflammatory skin disorder also known as eczema. The biologic drug came from Lilly’s $1.1

article thumbnail

Innovation key for boosting UK biopharma competitiveness

European Pharmaceutical Review

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

But increased competition is on the horizon. In 2020, and in an attempt to abate the drawback, Jazz got FDA approval for Xywav, which is a mixture of calcium, magnesium, and potassium salts that contains 92% less sodium than Xyrem. Competition starts to heat up. Classic treatment options. Xyrem is one of three that has a patent.

article thumbnail

The Top 10 Medical Device Success Podcasts in 2020!

Medical Device Success

35 podcasts were produced in our inaugural year of 2020. 1 Ep 4 – The Future of the Medical Device Industry in the Covid-19 Era, April 12, 2020. 2 Ep 6 – Selling in a Covid-19 Word – New Sales Practices, April 26, 2020. 3 Ep 10 – The Reopening, Covid-19 and what it means for Medical Devices, May 24, 2020.

Medical 100
article thumbnail

3 Insights From Re:Imagine Pharma Marketing 2020

Pharma Marketing Network

Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. Pharma Marketing 2020: The Enduring Impact . Rea ching HCP’s When Your Sales Force Can’t.

article thumbnail

Moderna’s Covid-19 vaccine sales forecast slashed amidst strong competition

Pharmaceutical Technology

Despite this, Spikevax’s average annual sales forecast has plummeted by 23% between H1 and H2 2022 according to GlobalData’s Coronavirus Disease 2019 (COVID-19) Sector Forecast reports, due to increasing competition from Pfizer’s Comirnaty, Novavax’s Nuvaxovid, and Covid-19 therapeutics.

article thumbnail

2020 Sales Hiring Forecast

Sales Talent

By comparing these forecasts to historical data, we developed our 2020 sales hiring forecast. 2020 Sales Hiring Forecast. Sales hiring in 2020 shows no signs of slowing down. Manpower forecasts a Q1 2020 Net Employment Outlook for the U.S. 4 percent in 2020. 2019 Sales Hiring in Review. YOY increase.

Sales 52